| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3572 |
| Trial ID | NCT06014073 |
| Disease | Non-Hodgkin's Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | ATHENA CAR-T cells |
| Generation | 2nd |
| Recruitment status | Recruiting |
| Title | TRAC and Power3 Genes Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-NHL |
| Year | 2023 |
| Country | China |
| Company sponsor | Chinese PLA General Hospital |
| Other ID(s) | CHN-PLAGH-BT-082 |
| Cohort1: Phase 1 | |||||||||||||
|
|||||||||||||
| Cohort2: Phase 2 | |||||||||||||
|
|||||||||||||